Stockreport

BTIG Initiates Invivyd (IVVD) Coverage, Cites VYD2311's Superior Market Potential Over Pemgarda [Yahoo! Finance]

Invivyd, Inc.  (IVVD) 
PDF initiated coverage of Invivyd with a Buy rating and $10 price target. BTIG maintained this stance on Invivyd, citing the company's established expertise in antibody prod [Read more]